drugset
drugset / Trial / NCT00726830

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

NCT00726830 ↗

Terminated 1 enrolled M.D. Anderson Cancer Center National Cancer Institute (NCI) · collab
RandomizedSingle-groupOpen-labelSupportive care

Summary

RATIONALE: Methadone, morphine, or oxycodone may help relieve pain caused by cancer. It is not yet known whether methadone is more effective than morphine or oxycodone in treating pain in patients with cancer. PURPOSE: This randomized clinical trial is studying methadone to see how well it works compared with morphine or oxycodone in treating pain in patients with cancer.

Timeline

Start
2009-03
Primary completion
2010-09
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Methadone Other / unclassified — Oral
Subject Morphine Other / unclassified — Oral
Subject Oxycodone Other / unclassified — Oral

Indications

cancer of unknown primary site central nervous system neoplasm leukemia lymphoproliferative syndrome myelodysplastic syndrome myelodysplastic/myeloproliferative disease myeloproliferative neoplasm plasma cell neoplasm precancerous condition